Arch Miller , MS, MD, FACS, FAAP, Becomes First In Oklahoma With Breakthrough, FDA-Cleared, Non-invasive ULTRASHAPE™ System For Immediate Fat Cell Destruction

Share Article

Fat Reduction Technology Generates Visible Results Within Two-Weeks Of Treatment

"One significant benefit of UltraShape is that we can customize the treatment with extra-ordinary accuracy to target and destroy fat cells immediately meeting each patient's goals"

Arch Miller, MS, MD, FACS, FAAP, a board-certified plastic surgeon is the first physician in the state to offer UltraShape™, a revolutionary treatment recently FDA cleared for Fat Cell Destruction.

The UltraShape System developed by medical device leader Syneron Candela is the first and only non-invasive fat reduction treatment that uses pulsed focused ultrasound to immediately and comfortably destroy fat cells, resulting in measurable outcomes in as little as two weeks.

The UltraShape device works by emitting waves of focused pulsed ultrasonic energy, converging at a closely confined area where patients want to target stubborn fat. Ultrasound is comfortably delivered to the treatment area, while keeping surrounding tissue, nerves and muscles intact and undamaged. Fat cells are destroyed and eliminated by the body’s natural processes as soon as two weeks after treatment, causing a very visible and immediate reduction.

"One significant benefit of UltraShape is that we can customize the treatment with extra-ordinary accuracy to target and destroy fat cells immediately meeting each patient’s goals,” states Dr. Miller. “Unlike traditional ultrasound technology, UltraShape distributes energy in pulses rather than in a single continuous delivery which can be painful. Nothing works faster than UltraShape to provide a safe and comfortable treatment experience without discomfort, lumps, bumps or soreness associated with many other non-invasive fat reduction treatments. Patients typically require three treatments at a two-week interval with average reduction of 1.3 to 2.5 inches.” Treatments take less than an hour and patients can go right back to their normal activities without any disruption.

In the randomized, controlled clinical study of UltraShape which was performed at three clinical sites in the US and one site outside of the US, a total of 150 subjects were treated and followed for up to four months. Ninety four percent of patients saw a measurable circumferential reduction with 90 percent of patients being satisfied with their treatment outcomes. This is one of the largest studies ever performed in the area of non-invasive aesthetics.

The UltraShape is a very versatile device that is effective for the reduction of fat deposits that are resistant to diet and exercise. UltraShape is FDA cleared for fat cell destruction and is used to contour and improve body shape.

The UltraShape device has been used in over 300,000 procedures worldwide, with an excellent safety and efficacy profile.

To learn more about UltraShape, our practice or to request a consultation, call us at (918) 215.2355, or visit us at

Tulsa Plastic Surgery
6585 S. Yale
Suite 315
Tulsa, OK 74136
About Syneron
Syneron Medical Ltd. is a leading global aesthetic device company with a comprehensive product portfolio and a global distribution footprint. The Company's technology enables physicians to provide advanced solutions for a broad range of medical-aesthetic applications including body contouring, hair removal, wrinkle reduction, improving the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. The Company sells its products under two distinct brands, Syneron and Candela.

For additional information, please visit

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Gina Bradford
Bradford MKTG
+1 (539) 664-7261
Email >